A deep passion for improving lives.

Metavention Company Hero Image Mobile Hero Company

One team aligned on one ultimate goal.

Our company is committed to challenging the status quo to deliver better treatment options to the millions of people who need them. Together, with patients and the healthcare professionals who care for them, we can effect real change in the lives of people suffering from metabolic diseases.

Leadership Team

Todd Berg

Todd Berg

President & CEO
Lisa Diehl

Lisa Diehl

Director, Therapy Development
James Ness

James Ness

Consulting Chief Financial Officer
A2

Kavitha Ganesan

Director, Advanced Therapies
Kent Lind

Kent Lind

SVP of Quality, Regulatory, & Operations
Adam Ahlstrom

Adam Ahlstrom

Director, Clinical
Jerry Grudem

Jerry Grudem

Director, Catheter Development
Jessica Rooney

Jessica Rooney

Associate Communications Manager
Dan Kollman

Dan Kollmann

Director, Console Development

Board of Directors

Kevin Hykes

Independent Director

Pete McNerney

Independent Director

Timothy Mills, Ph.D.

Managing Director,
Sanderling Ventures

Kirk Nielsen

Managing Partner
Vensana Capital

Ilan Lovinsky, Corporate Counsel

Partner
Gunderson Dettmer

Scientific Advisors

Bobak Azamian

Bobak R. Azamian, M.D., Ph.D.

Founder, Metavention, Inc.
CEO of Tarsus Pharmaceuticals, Inc.
Cherrington

Alan D. Cherrington, Ph.D.

Vanderbilt University Professor, Molecular Physiology and Biophysics and Jacquelyn A. Turner and Dorothy J. Turner Chair in Diabetes Research Medicine
Ibrahim Hanouneh

Ibrahim A. Hanouneh, M.D.

Director, Department of Gastroenterology and Hepatology, Abbott Northwestern Hospital, Minneapolis, MN Gastroenterologist and Hepatologist, MNGI Digestive Health, Minneapolis, MN Supplemental Consultant, Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN
Felix Mahfoud

Prof. Felix Mahfoud, M.D.

Saarland University, Germany
Interventional Cardiologist
Robert Rizza

Robert A. Rizza, M.D.

Mayo Clinic
Professor of Medicine, Division of Endocrinology, Diabetes, Nutrition and Metabolism
KRS

Krishna Rocha-Singh, MD, FACC, FAHA

Chief Scientific Officer, Prairie Heart Institute at St. John's Hospital
Springfield, IL
Markus Schlaich

Markus Schlaich, M.D., FAHA, FESC

Dobney Hypertension Centre, School of Medicine and Pharmacology
Royal Perth Hospital Unit, University of Western Australia
Robert Smith

Robert J. Smith, M.D.

Brown University
Professor of Medicine Emeritus, The Warren Alpert School of Medicine